Identification Latent Tuberculosis Infection In Dialysis Patients : A Systematic Review

hamidah retno wardani

Abstract


LTBI infection is a dormant condition of the tuberculosis organism. It is often defined as a condition without symptom with the tuberculosis organisms in the lung tissue, without clinical signs, or radiological signs. LTBI can become active TB in immunosuppressed hosts caused by comorbid disease or medical therapy such as patients with end-stage renal disease. Screening TB infection using examination tests such as the TST, QFT-G, and complete treatment in dialysis patients can avoid the progression of LTBI into active-TB. This research identified the incidence of LTBI in dialysis patients using the two-step TST and QFT-G. A Systematic Review study to identification the incidence of LTBI in dialysis patients using the Prefered Reporting Items for Systematic Review and Meta-analysis protocol. Derived from 67 related articles and obtained 4 articles using the Randomized Control Trial (RCT). Totally 516 dialysis patients and the study showed that the incidence of LTBI using two-step TST (cut off ≥ 10 mm) and QFT-G (≥ 35 IU/ml) showed that TST /QFT-G positive 68 patients (18.47%), only positive TST 22 patients (5.97 %), only positive QFT-G 77 patients (20.92%). This study showed that a high incidence of LTBI in dialysis patients. Early detection and complete treatment of LTBI should be performed in dialysis patients to avoid the reactivation of LTBI into active TB.


Keywords


ESRD; Haemodialysis patient; LTBI; TST; QFT-G.

Full Text:

PDF

References


Almufty, H, B., Abdulrahman, I, S., Merza, M, A. (2019). Latent tuberculosis infection among healthcare workers in Duhok Province: from screening to prophylactic treatment. Tropical Medicine and Infectious Disease, 4:85; doi: 10.3390/tropicalmed4020085

Anand, S., Bitton, A., & Gaziano T. (2013). The gap between estimated incidence of end-stage renal disease and use of therapy. PLOS ONE 2013; 8: e72860.

Anibarro, L., Trigo, M., Feijoó, D., Ríos, M., Palomares, L., Villaverde, APC., & González-Fernández, A. (2012). Value of the tuberculin skin testing and of an interferon-gamma release assay in haemodialysis patients after exposure to M. tuberculosis. BMC Infectious Diseases, 12:195

Anderson, S., Halter, J, B., Hazzard W R, et al. Prediction, progression, and outcomes of chronic kidney disease in older adults. (2009). J Am Soc Nephrol 2009; 20: 1199–1209.

Campbell, J, R., Krot, J., & Marra, F. (2016). Latent tuberculosis diagnostic tests to predict longitudinal tuberculosis during dialysis: a meta-analysis. International Journal Lung Disease, http://dx.doi.org/10.5588/ijtld.15.0825.

Canadian Thoracic Society and Public Health Agency of Canada. (2013). Canadian tuberculosis standards. 7th ed. Ottawa, ON, Canada: PHA. http://www.respiratoryguidelines.ca/tbstandards-2013. Accessed Oktober 2020.

CDC. (2019). TB laten : a guide for primary health care providers. (Online) 1 Agustus 2019’, Available from: https://www.cdc.gov/tb/publications/ltbi/treatment.htm#two.

Druszczynska, M., Kulbat, M, K., Fol, M., Wlodarczyk, M., Rudnicka, W. (2012). Latent M. tuberculosis Infection–pathogenesis, diagnosis, treatment and prevention strategies. Polish Journal of Microbiology.Vol. 61, No 1,3-10.

Houben, R, M, G., & Dodd, P, J. (2016). The global burden of TB laten : a re-estimation using mathematical modelling. PLOS ONE, 13(10): e1002152, doi:10.1371/journal. pmed.1002152.

Hussein, M, T., Yousef, L, M., & Ali, A, T. (2017). Detection of latent tuberculosis infection in hemodialysis patients: Comparison between the quantiferon-tuberculosis gold test and the tuberculin skin test. Egyptian Journal of Bronchology. DOI: 10.4103/ejb.ejb_19_17

Jha, V., Garcia-Garcia, G., Iseki, K., et al. (2013). Chronic kidney disease: global dimension and perspectives. Lancet Lond Engl, 382: 260–272.

Jahdali, H, A., Anwar, E., Ahmed., Hanan, H., Balkhy., Baharoon, S., Fayez, F., Hajeer, A, H, A., Memish, Z., & Sayyari, S, B, A. (2013). Comparison of the tuberculin skin test and quanti-FERON-TB gold in tuber (QFT-G) test for the diagnosis of latent tuberculosis in dialysis patients. Journal of Infection and Public Health, http://dx.doi.org/10.1016/j.jiph.2013.02.002.

Kim, H, W., & , J, S. (2018). Treatment of TB laten and its clinical efficacy. The Korean Academy of Tuberculosis and Respiratory Disease, Doi.org/10.4046/trd.2017.0052.

Lee, S, S, J., Chou, K, J., Dou, H, Y., Huang, T, S., Ni, Y, Y., Fang, H, C., Wu, K, S., Tsai, H, C., Wang, Y, H., Len, S, C., Lin, H, H., Chen, J, K., & Chen, Y, S. (2010). High prevalence of latent tuberculosis




DOI: https://doi.org/10.32528/ijhs.v13i2.6452

Refbacks

  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.

View My Stats